图书馆主页
数据库简介
最新动态
联系我们



返回首页


 刊名字顺( Alphabetical List of Journals):

  A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL


  检 索:         高级检索

期刊名称:SAUDI PHARMACEUTICAL JOURNAL

ISSN:1319-0164
出版频率:Bi-monthly
出版社:ELSEVIER, RADARWEG 29, AMSTERDAM, NETHERLANDS, 1043 NX
  出版社网址:http://www.elsevier.com/wps/find/homepage.cws_home
期刊网址:http://www.elsevier.com/wps/find/journaldescription.cws_home/722878/description
影响因子:4.33
主题范畴:PHARMACOLOGY & PHARMACY

期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)   



About the journal

The Saudi Pharmaceutical Journal is published every three months by the Saudi Pharmaceutical Society, with the cooperation of the College of Pharmacy, King Saud University. The Journal accepts high quality articles that conform to its scope and editorial standards. The scope encompasses various disciplines of pharmaceutical sciences and related clinical subjects that are of interest to practicing pharmacists and other health care professionals. The journal will publish original research articles, review articles, short communications, case studies, letters to the editors and book reviews. Abstracts of meetings and symposia will also be considered for publication. All submitted papers are subject to an extensive review by the editorial board and by a panel of international referees.


To minimize delays between manuscript submission, decision and publication, authors are requested to follow the "Instructions to authors" found elsewhere in this Journal. Conforming with all the steps listed in that section will facilitate the processing of your manuscript by the Editorial Board.


Accredited as a refereed Journal by the Scientific Council of King Saud University, Riyadh, Kingdom of Saudi Arabia.

 

Abstracting and Indexing

Science Citation Index Expanded


Instructions to Authors

Use of wordprocessing software

It is important that the file be saved in the native format of the wordprocessor used. The text should be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and replaced on processing the article. In particular, do not use the wordprocessor's options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. Do not embed "graphically designed" equations or tables, but prepare these using the wordprocessor's facility. When preparing tables, if you are using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of conventional manuscripts Do not import the figures into the text file but, instead, indicate their approximate locations directly in the electronic text and on the manuscript. See also the section on Electronic illustrations.
To avoid unnecessary errors you are strongly advised to use the "spell-check" and "grammar-check" functions of your wordprocessor.

Article structure

Subdivision - numbered sections

Divide your article into clearly defined and numbered sections. Subsections should be numbered 1.1 (then 1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included in section numbering). Use this numbering also for internal cross-referencing: do not just refer to "the text". Any subsection may be given a brief heading. Each heading should appear on its own separate line.
Use line numbering throughout your paper.

Introduction

State the objectives of the work and provide an adequate background, avoiding a detailed literature survey or a summary of the results.

Material and methods

Provide sufficient detail to allow the work to be reproduced. Methods already published should be indicated by a reference: only relevant modifications should be described.

Results

Results should be clear and concise. Show only those experimental results that are relevant to your objectives and conclusions and which you want to discuss.

Discussion

This should explore the significance of the results of the work, not repeat them. It should integrate your findings in a comprehensive picture and place them in the context of the existing literature. A combined Results and Discussion section can be appropriate. Avoid extensive citations and discussion of published literature.

For reviews the organisation of the paper can be different. It is however important that a review is more than a summary of the literature, an in-depth critical discussion is essential for acceptance of a review paper.

Conclusions

Conclusions contain essentially the 'take-home' message of a paper. Conclusions are not an extension of the discussion or a summary of the results. Authors are advised to list important implications of their work in form of a bulleted list. Conclusions must not contain references to the cited literature.

Appendices

If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix, Eq. (B.1) and so on.
It is also possible to add supplementary information on-line (see below).

Essential title page information

Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.

Author names and affiliations. Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name, and, if available, the e-mail address of each author.

Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that telephone and fax numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address.

Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a "Present address" (or "Permanent address") may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.



Abstract

A concise and factual abstract is required. The abstract should state briefly the purpose of the research, the principal results and major message. An abstract is often presented separately from the article, so it must be able to stand alone. For this reason, References should be avoided, but if essential, they must be cited in full, without reference to the reference list. Also, abbreviations should be avoided, but if essential they must be defined at their first mention in the abstract itself.

Keywords

Immediately after the abstract, provide a maximum of 6 keywords, avoid general and plural terms and multiple concepts (avoid, for example, "and", "of"). Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords will be used for indexing purposes. Use keywords that make your paper easy detectable for interested readers in literature databases. Repeating terms in the title is usually not needed.

Abbreviations

Nomenclature must be listed at the beginning of the paper and must conform to the system of standard SI units. Acronyms and abbreviations must be spelled out in full at their first occurrence in the text. In general, minimise the use of abbreviations so the paper remains easily understood by the general reader.

Acknowledgements

Collate acknowledgements in a separate section at the end of the article before the references and do not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language help, writing assistance or proof reading the article, etc.).

Electronic artwork

General points
• Make sure you use uniform lettering and sizing of your original artwork.
• Save text in illustrations as "graphics" or enclose the font.
• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Ensure that the figures can be understood without reading the text. Minimise use of abbreviations.
• Produce images near to the desired size of the printed version.
• Submit each figure as a separate file.

A detailed guide on electronic artwork is available at the Elsevier website:
http://www.elsevier.com/artworkinstructions.

Color artwork

Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and with the correct resolution. If, together with your accepted article, you submit usable color figures these will be reproduced in color at no cost. For further information on the preparation of electronic artwork, please see
http://www.elsevier.com/artworkinstructions.

Figure captions

Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A caption should comprise a brief title (not on the figure itself) and a description of the illustration, making it understandable independent of the text. Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations used. Prevent use of symbols in figures and captions.

Tables

Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables below the table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be sparing in the use of tables and ensure that the data presented in tables do not duplicate results described elsewhere in the article.
Minimise the use of symbols and abbreviations in the tables.

References

Citation in text

Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Any references cited in the abstract must be given in full. Unpublished results and personal communications are not recommended in the reference list, but may be mentioned in the text. If these references are included in the reference list they should follow the standard reference style of the journal and should include a substitution of the publication date with either "Unpublished results" or "Personal communication" Citation of a reference as "in press" implies that the item has been accepted for publication.
Only cite the original papers and those relevant for the work, no need to give a full literature review in the introduction/discussion. A large fraction of self-citations is general an indication that the authors didn't place their work well in the literature context.

Web references

As a minimum, the full URL should be given. Any further information, if known (DOI, author names, dates, reference to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the reference list) under a different heading if desired, or can be included in the reference list.

References in a special issue

Please ensure that the words 'this issue' are added to any references in the list (and any citations in the text) to other articles in the same Special Issue. Reference Style: All citations in the text should refer to:
1. Single author: the author's name (without initials, unless there is ambiguity) and the year of publication;
2. Two authors: both authors' names and the year of publication;
3. Three or more authors: first author's name followed by "et al." and the year of publication.
Citations may be made directly (or parenthetically). Groups of references should be listed first alphabetically, then chronologically.
Examples: "as demonstrated (Allan, 1996a, 1996b, 1999; Allan and Jones, 1995). Kramer et al. (2000) have recently shown ...."
List: References should be arranged first alphabetically and then further sorted chronologically if necessary. More than one reference from the same author(s) in the same year must be identified by the letters "a", "b", "c", etc., placed after the year of publication.
Examples:
Reference to a journal publication:
Van der Geer, J., Hanraads, J.A.J., Lupton, R.A., 2000. The art of writing a scientific article. J. Sci. Commun. 163, 51-59.
Reference to a book:
Strunk Jr., W., White, E.B., 1979. The Elements of Style, third ed. Macmillan, New York.
Reference to a chapter in an edited book:
Mettam, G.R., Adams, L.B., 1999. How to prepare an electronic version of your article, in: Jones, B.S., Smith , R.Z. (Eds.), Introduction to the Electronic Age. E-Publishing Inc., New York, pp. 281-304.
Web references: As a minimum, the full URL should be given. Any further information, if known (DOI, author names, dates, reference to a source publication, etc.), should also be given. Web references can be listed separately (e.g., after the reference list) under a different heading if desired, or can be included in the reference list.

Supplementary material

Elsevier accepts electronic supplementary material to support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier Web products, including
ScienceDirect. In order to ensure that your submitted material is directly usable, please ensure that data are provided in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file. Video files: please supply 'stills' with your files: you can choose any frame from the video or make a separate image. These will be used instead of standard icons and will personalize the link to your supplementary information. For more detailed instructions please visit our artwork instruction pages at http://www.elsevier.com/artworkinstructions.

Submission checklist

It is hoped that this list will be useful during the final checking of an article prior to sending it to the journal's Editor for review. Please consult this Guide for Authors for further details of any item.
Ensure that the following items are present:
One Author designated as corresponding Author:
• E-mail address
• Full postal address
• Telephone, mobile telephone and fax numbers
All necessary files have been uploaded
• Keywords
• All figure captions
• All tables (including title, description, footnotes)
Further considerations
• Manuscript has been "spellchecked" and "grammar-checked"
• References are in the correct format for this journal
• All references mentioned in the Reference list are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Web)
• Color figures are clearly marked as being intended for color reproduction on the Web (free of charge) and in print or to be reproduced in color on the Web (free of charge) and in black-and-white in print
• If only color on the Web is required, black and white versions of the figures are also supplied for printing purposes

AFTER ACCEPTANCE

Use of the Digital Object Identifier

The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information. The correct format for citing a DOI is shown as follows (example taken from a document in the journal Physics Letters B):
doi:10.1016/j.physletb.2003.10.071
When you use the DOI to create URL hyperlinks to documents on the web, they are guaranteed never to change.


Editorial Board

Editorial Office

Saudi Pharmaceutical Society, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia, Email: spj@ksu.edu.sa

 

Editorial Board

 

J.B. Dressman

Institute of Pharmaceutical Technology Biocenter, Johann Wolfgang Goethe University, Max-von-Laue-Str. 9 ,Goethe University, 60438 Frankfurt am Main, Germany, Tel: +(49) 69-79829680, Fax: +(49) 69-79829724, Email: dressman@em.uni-frankfurt.de

 

M. Ghaleb

University of Hertfordshire, Hatfield, Hertfordshire, AL10 9AB, United Kingdom, Tel: +(44) 0 1707285087, Fax: +(44) 0 1707284870, Email: m.ghaleb@herts.ac.uk

 

F. Jamali

Editor-in-Chief of Journal of Pharmacy & Pharmaceutical Science (JPPS), 3118 Dentistry / Pharmaceutical Center, University of Alberta Campus, Edmonton, Alberta, T6G 2N8,Canada, Tel: +(1) 780-4922807, Fax: +(1) 780-4920951, Email: fjamali@pharmacy.ualberta.ca

 

J. Lehmann

Department of Pharmaceutical Chemistry, Institute of Pharmacy, Friedrich-Schiller-University, Jena , Philosophenweg, 14, D-07743 Jena, Germany, Tel: +(49) 0-3641949803, Fax: +(49) 0-3641949802, Email: j.lehmann@uni-jena.de

 

S.H. Neau

Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, 600 South 43rd Street, Philadelphia, PA 19104, USA, Tel: +(1) 215-5968825, Fax: +(1) 215-5967450, Email: s.neau@usp.edu

 

A. Sakr

Board of Trustees Chair Assistant, Graduate Studies, Research & International Affairs, Future University, Egypt

 

R.J. Sawchuk

Professor Emeritus, Morse Alumni Distinguished Teaching Professor, Director, Bioanalytic and Pharmacokinetic Services Laboratory, Department of Pharmaceutics, College of Pharmacy, University of Minnesota

 

A.M. Shibl

Professor of Microbiology, Department of Pharmaceutics, College of Pharmacy, King Saud University

 

Advisory Board

E.M. Abdel-Moety

Professor of Analytical Chemistry, Faculty of Pharmacy, Cairo University, Kasr El-Aini, Cairo, Egypt, Tel: +(202) 6177855, Fax: +(202) 6173262, Email: eamoety@web.de

 

T. Aboul-Fadl

Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Tel: +(966) 1-4677341, Fax: +(966) 1-4676220, Email: Fadl@ksu.edu.sa

 

M.M.S. Ahmed

Associate Professor of Pharmacology, Department of Pharmacology, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh, Saudi Arabia, Tel: +(966) 1-4677267, Fax: +(966) 1-4677200, Email: sayedahmedmm@hotmail.com

 

M.N. Al-Ahdal

King Faisal Specialist Hospital and Research Center, P.O. Box 3354, Riyadh 11211, Saudi Arabia, Tel: +(966) 1-4427867, Fax: +(966) 1- 4427858, Email: ahdal@kfshrc.edu.sa

 

F.K. Alanazi

Associate Professor of Pharmaceutics, Department of Pharmaceutics, College of Pharmacy, King Saud University

 

A.A. AlHaidar

Department of Pharmacology, College of Medicine, King Saud University, P.O. Box 2925, Riyadh 11461, Saudi Arabia, Tel: +(966) 1-4671346, Fax: +(966) 1-4679466, Email: aqahaider@hotmail.com

 

M.M. Alharbi

Chairman of Pharmacology Department, College of Pharmacy, King Saud University, Tel: +(966) 1-4677189, Fax: +(966) 1-4677200, Email: mmzharbi@ksu.edu.sa

 

A. Al-jedai

Director of Pharmacy Division, Senior Clinical Pharmacist, Solid Organ Transplant, College of Medicine- Al Faisal University & King Faisal Specialist Hospital & Research Centre, P.O. Box 3354 MBC # 11, Riyadh 11211, Saudi Arabia, Tel: +(966) 1-4427061, Fax: +(966) 1-4227608, Email: jedai@kfshrc.edu.sa

 

O. Al-Shabanah

Department of Pharmacology, College of Pharmacy, King Saud University, Tel: +(966) 1- 4677179, Fax: +(966) 1- 4677200, Email: shabanah@ksu.edu.sa

 

Y.A. Asiri

Dean of College of Pharmacy, Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia, Tel: + (966) 1-4677370, Fax: + (966) 1-4676383, Email: yasiri@ksu.edu.sa

 

G. Bao

Robert A. Milton Chair in Biomedical Engineering, College of Engineering Distinguished Professor, 313 Ferst Drive, Suite 2115, Atlanta, Georgia 30332-0535, USA, Tel: +(1) 404-3850373, Fax: +(1) 404-8944243, Email: gang.bao@bme.gatech.edu

 

M.A. Bayomi

Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia, Tel: +(966) 1-4677365, Fax: +(966) 1-4676295, Email: bayomimohsen@hotmail.com

 

I.A. Darwish

Editor of International Journal of Biomedical Sciences, Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia, Tel: +(966) 1-4677348, Fax: +(966) 1-4676220, Email: idarwish@ksu.edu.sa

 

F.M. Eckel

Editor-in-Chief of Pharmacy Times, Hospital Pharmacy Practice, School of Pharmacy, University of North Carolina at Chapel Hill, Beard Hall, Chapel Hill, NC 27599-7360, USA, Tel: +(1) 919-962-0034, Fax: +(1) 919-966-6919, Email: fred_eckel@unc.edu

 

A.A. El-Emam

Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia, Tel: +(966) 1-4677350, Fax: +(966) 1-4676220, Email: aelemam@ksu.edu.sa

 

A.O.S. El-Kadi

Faculty of Pharmacy and Pharmaceutical Sciences, 3126 Dentistry/Pharmacy Center, University of Alberta, Tel: +(1) 780-492-3071, Fax: +(1) 780-492-1217, Email: aelkadi@pharmacy.ualberta.ca

 

H.A.M. Elsaghir

Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia, Tel: +(966) 551001679, Fax: +(966) 1-2913735, Email: hanaaelsaghir@yahoo.com

 

H.I. El-Subbagh

Professor, Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences & Pharmaceutical Industries, Future University, Cairo 12311, Egypt

 

H.H. Hagar

Department of Pharmacology, College of Medicine, King Khalid University Hospital, King Saud University, P.O. Box 2925, Riyadh 11461, Saudi Arabia, Tel: +(966) 1-4786768, Fax: +(966) 1-4786768, Email: hananhhagar@yahoo.com

 

M.M. Hefnawy

Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Tel: +(966) 1-4677346, Fax: +(966) 1-4676220, Email: mhefnawy2003@yahoo.com

 

A. Kadi

Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Tel: +(966) 1-4677344, Fax: +(966) 1-4676220, Email: akadi@ksu.edu.sa

 

A.T. Khalil

Department of Pharmacognosy, College of Pharmacy, King Saud University, Tel: +(966) 1-4677248, Fax: +(966) 1-4677245, Email: prof_kal@ksu.edu.sa

 

G.M.E. Maghraby

Department of Pharmaceutical Technology, College of Pharmacy, University of Tanta, Tanta, Egypt, Tel: +(20) 106587189, Fax: +(20) 403335466, Email: gmmelmag@yahoo.com

 

M.A. Mansour

Department of Pharmacology, College of Pharmacy, King Saud University, Tel: +(966) 1-4675492, Fax: +(966) 1-4677200, Email: mansour1960us@yahoo.com

 

W.H.S. Mansy

Supervisor of Academic Affair Unit-Male section, Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Tel: +(966) 1-4677491, Fax: +(966) 1-4677480, Email: wsayed@ksu.edu.sa

 

A.Y. Mayet

Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Tel: +(966) 1-4677487, Fax: +(966) 1-4677480, Email: iymayet@ksu.edu.sa

 

J.L. McLaughlin

Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, 575 Stadium Mall Drive, West Lafayette, IN 47907, USA, Tel: +(1) 765 494-1403, Fax: +(1) 765 494-1414, Email: mclaughj@purdue.edu

 

M.N. Nagi

Department of Pharmacology, College of Pharmacy, King Saud University, Tel: +(966) 1- 46771181, Fax: +(966) 1- 4677200, Email: mnagi@ksu.edu.sa

 

A.A. Radwan

College of Pharmacy, Department of Pharmaceutics, P.O. Box 2457, Riyadh 11451, Saudi Arabia, Tel: + (966) 1-4670562, Fax: + (966) 1- 4676295, Email: dhna_2001@hotmail.com

 

S.A.F. Rostom

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, P.O. Box 80205, Jeddah 21589, Saudi Arabia, Tel: +(966) 2-6420295, Fax: +(966) 2-6408404, Email: sherifrostom@yahoo.com

 

A.A.M. Wahbi

Emeritus Professor, Faculty of Pharmacy, University of Alexandria, Alexandria 21521, Egypt

 

A.E.B. Yassin

Department of Pharmaceutics, College of Pharmacy, King Saud University, Tel: +(966) 1-4677499, Fax: +(966) 1-4676295, Email: ayassin@ksu.edu.sa



 返回页首 


邮编:430072   地址:中国武汉珞珈山   电话:027-87682740   管理员Email:
Copyright © 2005-2006 武汉大学图书馆版权所有